Epigenomics AG01.04.2020 / 12:31 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]
Year: 2020
01. April 2020
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Read more
31. March 2020
Epigenomics AG successfully completes capital increase
Epigenomics AG / Key word(s): Capital IncreaseEpigenomics AG successfully completes capital increase 31-March-2020 / 09:02 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. NOT FOR PUBLICATION, DISTRIBUTION […]
30. March 2020
Epigenomics AG decides to increase share capital by way of private placement
Epigenomics AG / Key word(s): Capital Increase/Corporate ActionEpigenomics AG decides to increase share capital by way of private placement 30-March-2020 / 19:53 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content […]
17. March 2020
Epigenomics Announces Postponement of Annual General Meeting due to Coronavirus and Preliminary 2019 Flash Financial Results
DGAP-News: Epigenomics AG / Key word(s): AGM/EGM/Preliminary Results17.03.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Epigenomics Announces Postponement of Annual General Meeting due to Coronavirus and Preliminary 2019 Flash Financial Results Berlin (Germany), March 17, 2020 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY; the “Company”), today announced the postponement […]
05. March 2020
Epigenomics AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Epigenomics AG05.03.2020 / 15:36 Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.The issuer is solely responsible for the content of this announcement. Notification of Major Holdings 1. Details of issuer Name: Epigenomics AG Street: Geneststraße 5 Postal code: 10829 City: BerlinGermany Legal Entity Identifier (LEI): 549300X1C4U862NDLN97 2. […]
02. March 2020
Centers for Medicare & Medicaid Services open NCD review process for Epi Pro Colon
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous02.03.2020 / 08:00 The issuer is solely responsible for the content of this announcement. Centers for Medicare & Medicaid Services open NCD review process for Epi Pro Colon Opening of review process guarantees reimbursement decision within next nine months Results of microsimulation model published in November 2019 show competitiveness […]